Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Ifosfamide × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 5 Sarcoma, Ewing 4 Osteosarcoma 3 Lymphoma, Large B-Cell, Diffuse 3 Sarcoma, Clear Cell 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neurofibrosarcoma 2 Nerve Sheath Neoplasms 2 Lymphoma 2 Liposarcoma 2 Histiocytoma, Angiomatoid Fibrous 2 Granuloma, Plasma Cell 2 Fibrosarcoma 2 Dermatofibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Wilms Tumor 1 Vascular Neoplasms 1 Teratoma 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Perivascular Epithelioid Cell Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Adipose Tissue 1 Neoplasm Metastasis 1

Interventions

Cyclophosphamide 16 Rituximab 13 fludarabine 10 pirtobrutinib 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 glofitamab 5 Doxorubicin 5 venetoclax 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Leukapheresis 4 Biopsy 4 zanubrutinib 3 polatuzumab vedotin 3 pembrolizumab 3 obinutuzumab 3 Lenalidomide 3 Etoposide 3 Dexamethasone 3 Bendamustine Hydrochloride 3 tazemetostat 2 tafasitamab 2 axicabtagene ciloleucel 2 acalabrutinib 2 Gemcitabine 2 Cytarabine 2 Cisplatin 2 Calcium Dobesilate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06230224 2026-02-06

OLYMPIA-4

Regeneron Pharmaceuticals

Phase 3 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡